Cell Lysis Market Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
The first stage in protein
extraction is cell lysis, which is then employed for a variety of applications
such as enzyme engineering and protein labelling. Furthermore, cell lysis is a
key stage in studying protein-protein interactions, which contributes to the
growth of the cell lysis market. Players in the global cell lysis market are
focused on R&D in order to introduce advanced products utilised in the cell
lysis process. Furthermore, rising demand for cell-based therapy for cancer
treatment is likely to drive growth in the cell lysis market.
Cell
lysis market growth is being driven by increased research and
development in the fields of proteomics and genomics, as well as the high
prevalence of infectious illnesses and cancer. Cell-based therapy advancements
and approvals are projected to drive the cell lysis industry forward. For
example, in May 2022, Novartis AG, a global healthcare company, announced that
the FDA has given accelerated clearance for Kymriah (tisagenlecleucel) for the
treatment of adult patients with relapsed or refractory (r/r) follicular
lymphoma (FL) after two or more lines of systemic therapy. Kymriah is now FDA
authorised for three indications and is the only CAR-T cell therapy that is
licenced for both adults and children.
COVID-19 has had three major
effects on the economy: directly influencing medication and vaccine
manufacturing and demand, disrupting distribution routes, and having a
financial impact on enterprises and financial markets. Several countries,
including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and
others, are experiencing difficulties transporting drugs and vaccines from one
location to another as a result of nationwide lockdowns.
Comments
Post a Comment